CAU
EXEL icon

Caxton Associates (UK)’s Exelixis EXEL Stock Holding History

Caxton Associates (UK)’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
4,218
-1,017
-19% -$49.5K ﹤0.01% 686
2026
Q1 		$225K Sell
5,235
-2,040
-28% -$87.7K 0.01% 686
2025
Q4 		$319K Sell
7,275
-6,048
-45% -$250K 0.01% 603
2025
Q3 		$550K Sell
13,323
-11,237
-46% -$452K 0.01% 440
2025
Q2 		$1.08M Sell
24,560
-8,948
-27% -$358K 0.03% 308
2025
Q1 		$1.24M Buy
+33,508
New +$1.19M 0.04% 283

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caxton Associates (UK)'s EXEL Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Exelixis (EXEL) stake by 19% in Q2 2026, selling an estimated $49.5K and leaving 4,218 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Caxton Associates (UK) first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.24M in Q1 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Caxton Associates (UK) held 4,218 shares of Exelixis worth $230K as of Q2 2026.
  • Caxton Associates (UK) sold 1,017 Exelixis shares in Q2 2026, an estimated $49.5K.
  • Exelixis made up ﹤0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #686 holding.
  • Caxton Associates (UK) first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s Exelixis position peaked at $1.24M in Q1 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.